Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BBD-1 in Hypersensitivity Reaction (IgA) Vasculitis
NCT07595367Phase 2Recruiting
- Start
- Aug 2026
- Primary completion
- Aug 2028
- Modality
- Biologic
- Countries
- 2
01
Overview
A Phase 2 trial of BBD-1 in immunoglobulin A vasculitis. Started Aug 2026; status: recruiting.
02
Drugs
BBD-1
03
Conditions
immunoglobulin A vasculitis
Beyond the preview
Go deeper on NCT07595367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07595367.